<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03919305</url>
  </required_header>
  <id_info>
    <org_study_id>CVT-China</org_study_id>
    <nct_id>NCT03919305</nct_id>
  </id_info>
  <brief_title>Cerebral Venous Thrombosis Cohort Study in China Mainland</brief_title>
  <acronym>CCC</acronym>
  <official_title>Cerebral Venous Thrombosis Cohort Study in China Mainland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Municipal Science &amp; Technology Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was aimed to reveal the clinical features,natural history of the diseases and
      current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood
      samples and cerebrospinal fluid samples will be collected after recruitment to reveal the
      pathological mechanisms of CVT and identify the biomarkers for CVT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      cerebral venous thrombosis (CVT) is caused by a clot in the cerebral vein, which resulted in
      an obstruction of the blood outflow. CVT mainly includes cerebral venous sinus thrombosis,
      deep cerebral vein thrombosis and cortical vein thrombosis. However, the epidemiological
      features of CVT in China mainland remained obscure. This study was aimed to establish a
      multicenter cohort recruiting patients with CVT across 31 provinces and municipalities in
      China mainland. Clinical features,natural history of the diseases and current therapeutic
      situations will be analyzed to reveal the epidemiological features of CVT. Blood samples and
      cerebrospinal fluid samples will be collected after recruitment to reveal the pathological
      mechanisms of CVT and identify the biomarkers for CVT. Patients will be followed-up at 1, 3,
      6, 12 months from baseline to evaluate the clinical prognosis and therapeutic outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">May 31, 2029</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death rate</measure>
    <time_frame>1 year from baseline</time_frame>
    <description>A combination of death form of all causes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional independence</measure>
    <time_frame>1 year from baseline</time_frame>
    <description>Defined as modified Rankin score (0-5) equal to or lower than 2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence of cerebral venous sinus thrombosis, deep cerebral venous thrombosis and cortical vein thrombosis</measure>
    <time_frame>1 year from baseline</time_frame>
    <description>Diagnosed by DSA, MRV, CTV or HR-MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of hemorrhagic complication</measure>
    <time_frame>1 year from baseline</time_frame>
    <description>Extracranial hemorrhage (fall in hemoglobin of 2 gram/dl or more within 48 hours) or intracranial hemorrhage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of sinus wall rupture</measure>
    <time_frame>1 year from baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of acute ischemic stroke</measure>
    <time_frame>1 year from baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of acute myocardial infarction</measure>
    <time_frame>1 year from baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of pulmonary embolism</measure>
    <time_frame>1 year from baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of deep venous thrombosis</measure>
    <time_frame>1 year from baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of epilepsy</measure>
    <time_frame>1 year from baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of allergic reaction</measure>
    <time_frame>1 year from baseline</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Cerebral Venous Sinus Thrombosis</condition>
  <condition>Deep Cerebral Vein Thrombosis</condition>
  <condition>Cortical Vein Thrombosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA detection will be conducted in a ramdom selection of 300 blood samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical
        vein thrombosis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein
        thrombosis diagnosed by digital subtraction angiography (DSA), magnetic resonance
        venography (MRV), computed tomography venography (CTV) or high-resolution magnetic
        resonance imaging (HR-MRI).

        Exclusion Criteria:

        • None of the patient, trustee or immediate family members signed the informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xunming Ji, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Min Li, MD, PhD</last_name>
    <phone>+86-18701519698</phone>
    <email>812879698@qq.com</email>
  </overall_contact>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2019</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Ji Xunming,MD,PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cerebral venous sinus thrombosis</keyword>
  <keyword>Deep cerebral vein thrombosis</keyword>
  <keyword>Cortical vein thrombosis</keyword>
  <keyword>Cohort study</keyword>
  <keyword>Real world evidence</keyword>
  <keyword>Observational study</keyword>
  <keyword>China mainland</keyword>
  <keyword>Cerebral venous system thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinus Thrombosis, Intracranial</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 16, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/05/NCT03919305/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 16, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/05/NCT03919305/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

